Kruppel-like factor 13 acts as a tumor suppressor in thyroid carcinoma by downregulating IFIT1

BACKGROUND: Kruppel-like factor 13 (KLF13) is a transcription factor and plays an important role in carcinogenesis.

However, the significance of KLF13 in thyroid carcinoma (THCA) is underdetermined.

In this study, we aimed to explore the clinical relevance and function of KLF13 in the progress of THCA.

METHODS: The expression of KLF13 in thyroid carcinoma and normal tissue was investigated by qPCR and IHC assay.

The expression of KLF13 and IFIT1 in cell samples was investigated with Western blot assay.

Cell proliferation ability was detected with CCK8 and colony formation assay.

Cell growth in vivo with or without KLF13 overexpression was evaluated on a xenograft model.

Cell migration ability was measured with Transwell assay.

Cell cycle was detected with flow cytometer.

The downstream genes of KLF13 were screened using RNA-seq assay.

Luciferase activity was employed to assess the transcriptional regulation of KLF13 on IFIT1 promoter.

RESULTS: KLF13 expression was downregulated in THCA samples.

KLF13 knockdown and overexpression promoted and inhibited the proliferation and migration of THCA cells, respectively.

The RNA-seq, RT-qPCR and immunoblotting data showed that KLF13 knockdown significantly potentiated IFIT1 expression at both mRNA and protein levels.

Luciferase assays showed that KLF13 suppressed the transcription activity of IFIT1 promoter.

Besides, IFIT1 upregulation was critical for the proliferation and migration of THCA cell lines.

Lastly, silencing of IFIT1 greatly reversed the proliferation and migration induced by KLF13 knockdown.

CONCLUSIONS: In conclusion, KLF13 may function as an anti-tumor protein in THCA by regulating the expression of IFIT1 and offer a theoretical foundation for treating thyroid carcinoma.

SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13062-023-00422-5.